Does Rallies show Form 4 insider transactions for XRAY?

Yes. Rallies tracks XRAY insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is XRAY research on Rallies investment advice?

No. Rallies provides research, data, and educational context for XRAY. It does not provide personalized investment advice.

XRAY (DENTSPLY SIRONA Inc.) Stock Analysis - Insider Trades

DENTSPLY SIRONA Inc. (XRAY) is a publicly traded Healthcare sector company. As of May 21, 2026, XRAY trades at $9.99 with a market cap of $1.97B and a P/E ratio of 1.92. XRAY moved +1.03% today. Year to date, XRAY is -15.25%; over the trailing twelve months it is -41.11%. Its 52-week range spans $9.41 to $27.44. Analyst consensus is neutral with an average price target of $13.88. Rallies surfaces XRAY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading XRAY stock inside the company?

Recent XRAY insider activity includes LUCIER GREGORY T bought 15.00K, Forbes James D bought 5.00K, LUCIER GREGORY T bought 22.45K, Forbes James D bought 5.00K, and LUCIER GREGORY T bought 27.55K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

XRAY Key Metrics

Key financial metrics for XRAY
Metric	Value
Price	$9.99
Market Cap	$1.97B
P/E Ratio	1.92
EPS	$5.19
Dividend Yield	0.16%
52-Week High	$27.44
52-Week Low	$9.41
Volume	0
Avg Volume	0
Revenue (TTM)	$24.78B
Net Income	$3.69B
Gross Margin	58.94%

Recent XRAY Insider Trades

LUCIER GREGORY T bought 15.00K (~$186.68K) on Mar 9, 2026.
Forbes James D bought 5.00K (~$62.40K) on Mar 9, 2026.
LUCIER GREGORY T bought 22.45K (~$314.86K) on Mar 3, 2026.
Forbes James D bought 5.00K (~$67.34K) on Mar 3, 2026.
LUCIER GREGORY T bought 27.55K (~$392.52K) on Mar 2, 2026.

Latest XRAY News

Dentsply Sirona Reports $880M Q1 Sales, 48.5% Gross Margin, Launches AI Diagnostic Tool — May 5, 2026
Dentsply Sirona Expands Southeast CEREC Distribution and Faces Q1 Margin Pressure — May 4, 2026
Dentsply Sirona Debuts FDA-Cleared AI Diagnostic Boosting PARL Detection 46% — May 4, 2026
Dentsply Sirona Unit Rolls Out 24-Hour Surity Male Catheter for 13M U.S. Patients — Apr 30, 2026
FDA Clears First Dental-Dedicated MRI with Under-20-Minute Workflow — Mar 9, 2026

XRAY Analyst Consensus

14 analysts cover XRAY: 0 strong buy, 3 buy, 9 hold, 2 sell, 0 strong sell. Consensus rating is neutral. Average price target: $13.88.

Common questions about XRAY

Who is trading XRAY stock inside the company?: Recent XRAY insider activity includes LUCIER GREGORY T bought 15.00K, Forbes James D bought 5.00K, LUCIER GREGORY T bought 22.45K, Forbes James D bought 5.00K, and LUCIER GREGORY T bought 27.55K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for XRAY?: Yes. Rallies tracks XRAY insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is XRAY research on Rallies investment advice?: No. Rallies provides research, data, and educational context for XRAY. It does not provide personalized investment advice.